A phase I/II trial of escalating doses of recombinant human keratinocyte growth factor (rHuKGF) in head & neck cancer (HNC) patients receiving radiotherapy (RT) with concurrent chemotherapy (CCT)

David M. Brizel, Bin Yao, Don R. Goffinet et al.|International Journal of Radiation Oncology*Biology*Physics|2001

Cited by 22